Surgical and Medical Management of Pancreatic Tumors: Indication, Techniques, and Prognostic Factors

Dear Colleagues,

Pancreatic masses represent a clinically significant concern due to their rising global incidence, with pancreatic cancer now ranking among the top causes of cancer-related deaths worldwide.

Pancreatic masses represent a heterogeneous spectrum of neoplasms, with the most common being pancreatic ductal adenocarcinoma, neuroendocrine tumors, and IPMNs. Timely and accurate differentiation among these entities is essential in devising effective therapeutic strategies. Recent advancements in diagnostic modalities, surgical techniques, and perioperative care have significantly influenced the management of pancreatic tumors.

Pancreatic neoplasms can significantly impact patient outcomes based on their nature, origin, and behavior. Some of these tumors may benefit from upfront surgery, while others may need medical therapy alone or prior to surgery.

Pancreatic surgery can be performed using open techniques or minimally invasive approaches, such as laparoscopic or robotic-assisted surgery, depending on the specific case and the surgeon’s experience.

This Special Issue will focus on the surgical and medical management of patients with pancreatic tumors, addressing critical aspects such as neoadjuvant therapy, adjuvant therapy, surgical techniques, short- and long-term outcomes, survival rates, and prognostic factors in recurrence.

Additionally, this Special Issue will explore the factors influencing outcomes, short- and long-term survival, and recurrence rates.

By addressing these multifaceted topics, this Special Issue will provide a comprehensive overview of the current state of the management of pancreatic tumors, offering insights into improving patient outcomes.

This Special Issue will showcase original research, reviews, and case reports that highlight innovative treatment approaches or novel therapies in the field of pancreatic tumors.

We look forward to receiving your contributions.

Dr. Michele Tedeschi
Dr. Antonella Delvecchio
Dr. Riccardo Memeo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.